Browse Category

Solutions - Page 12

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

Cellares to expand cell therapy factory-in-a-box to Europe with new Netherlands facility

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after inking a long-term lease for space that will house manufacturing and offices in the Netherlands.

January 12, 2026

News·Solutions

Acuitas takes majority stake in Montreal-based RNA construct manufacturer

Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based and privately held RNA Technologies & Therapeutics in a move to scale the latter’s operations around high-end RNA

January 8, 2026

News·Solutions

R&D Operations Bottlenecks in Large Life Sciences Organizations: What can MedTech Leaders Do?

Medical device innovation is accelerating across nearly every therapeutic area. Software-enabled platforms, connected devices, and artificial intelligence are reshaping how products are conceived, developed, and deployed in clinical practice. Yet for many

January 7, 2026

Solutions

Daiichi Sankyo tallies $1.9B in planned Enhertu manufacturing investments: Nikkei

The company is planning Enhertu manufacturing expansions in the U.S., China, Japan and Germany that total $1.9 billion, Nikkei reported.

January 5, 2026

News·Solutions

AstraZeneca, betting on radiopharmaceuticals, extends Niowave isotope supply deal by 10 years

Pharma giant AstraZeneca extended its supply deal with Michigan-based medical radioisotope producer Niowave by 10 years, teeing up the delivery of Actinium-225 that has shown promise as a component in targeted cancer

December 23, 2025

News·Solutions

Incog to spend $200M on capacity boost at Indiana sterile injectables plant

Incog BioPharma, a sterile injectables CDMO, plans to shell out about $200 million to boost production capacity at its Fishers, Indiana, manufacturing site.

December 22, 2025

News·Solutions

Samsung Biologics pays GSK $280M to secure first US manufacturing site

Samsung Bio’s U.S. subsidiary will pay $280 million to acquire GSK’s Human Genome Sciences and its two pharmaceutical manufacturing plants at a campus in Rockville, Maryland. The site, which will mark Samsung

December 22, 2025

News·Solutions

FDA outlined concerns with Elevidys’ manufacturing at Catalent site, Form 483 shows

The Elevidys-related manufacturing shortfalls were described in one of two Form 483s tied to FDA inspections that came before Catalent’s layoff spree at its Maryland gene therapy manufacturing business.

December 19, 2025

News·Solutions

Bicycle gets radiopharmaceutical push from UK pact for reprocessed uranium

After seeing some of its financial momentum slow this year, Bicycle Therapeutics got a push from two U.K. nuclear agencies in the form of up to 440 tons of reprocessed uranium the

December 18, 2025

News·Solutions

Novo gets FDA warning letter at troubled Indiana site formerly owned by Catalent

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up last year, was hit with a warning letter from the FDA.

December 16, 2025

News·Solutions

Previous 1 … 10 11 12 13 14 … 20 Next

Go toTop